Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease
- PMID: 35332111
- PMCID: PMC8987457
- DOI: 10.7570/jomes22021
Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease
Abstract
Because of the global obesity epidemic, the incidence and prevalence of nonalcoholic fatty liver disease (NAFLD) have increased worldwide, including among Koreans. Recently, the incidence rate of NAFLD in Korea was reported to be 45.1 per 1,000 person-years, and the prevalence as approximately 30% depending on the diagnostic methods used. The incidence of advanced fibrosis and hepatocellular carcinoma, as well as all-cause and liver-related mortality in NAFLD patients has increased substantially, imposing considerable public health costs in Korea. Genetic, demographic, environmental, and clinical factors are involved in the pathogenesis of NAFLD. Some genetic variants, such as patatin-like phospholipase domain-containing 3 (PNPLA-3) and sorting and assembly machinery component 50 (SAMM-50), play a major role in the occurrence of NAFLD. The risk of NAFLD and fibrosis increases with advancing age and in men. Nutritional factors, inadequate exercise, and sleep duration are also associated with increased risk of NAFLD. Obesity is a major risk factor for NAFLD; however, NAFLD in lean individuals has been noted in recent studies. Insulin resistance, type 2 diabetes, and metabolic syndrome and its components are closely associated with NAFLD development and liver fibrosis with various underlying mechanisms. Sarcopenia likely shares a common pathophysiology with NAFLD. The rapidly increasing incidence and prevalence of NAFLD and its complications, as well as the associated healthcare burden, warrant early assessment of NAFLD and its risk factors to prevent NAFLD-related complications in high risk groups.
Keywords: Epidemiology; Incidence; Nonalcoholic fatty liver disease; Prevalence; Risk factor.
Conflict of interest statement
Ga Eun Nam has worked as an Associate Editor of the journal since 2020. However, she was not involved in peer reviewer selection, evaluation, or the decision process for this article. There are no other potential conflicts of interest relevant to this article to report.
Figures
Similar articles
-
The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease.Medicines (Basel). 2019 Mar 18;6(1):41. doi: 10.3390/medicines6010041. Medicines (Basel). 2019. PMID: 30889791 Free PMC article. Review.
-
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.World J Gastroenterol. 2017 Dec 21;23(47):8263-8276. doi: 10.3748/wjg.v23.i47.8263. World J Gastroenterol. 2017. PMID: 29307986 Free PMC article. Review.
-
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22. Hepatology. 2016. PMID: 26707365 Review.
-
Magnitude of Nonalcoholic Fatty Liver Disease: Eastern Perspective.J Clin Exp Hepatol. 2019 Jul-Aug;9(4):491-496. doi: 10.1016/j.jceh.2019.01.007. Epub 2019 Feb 7. J Clin Exp Hepatol. 2019. PMID: 31516265 Free PMC article. Review.
-
Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammation.Curr Opin Clin Nutr Metab Care. 2010 Jul;13(4):391-6. doi: 10.1097/MCO.0b013e32833a87cc. Curr Opin Clin Nutr Metab Care. 2010. PMID: 20473151 Review.
Cited by
-
Doxorubicin Attenuates Free Fatty Acid-Induced Lipid Accumulation via Stimulation of p53 in HepG2 Cells.Biomol Ther (Seoul). 2024 Jan 1;32(1):94-103. doi: 10.4062/biomolther.2023.200. Biomol Ther (Seoul). 2024. PMID: 38148555 Free PMC article.
-
Leisure-Time Physical Activity in Subjects with Metabolic-Dysfunction-Associated Steatotic Liver Disease: An All-Cause Mortality Study.J Clin Med. 2024 Jun 27;13(13):3772. doi: 10.3390/jcm13133772. J Clin Med. 2024. PMID: 38999337 Free PMC article.
-
Liver Stiffness Is Associated with the Burden of Carotid and Systemic Atherosclerosis in an Unorganized Cohort of Patients 40-64 Years Old.Diagnostics (Basel). 2022 Sep 27;12(10):2336. doi: 10.3390/diagnostics12102336. Diagnostics (Basel). 2022. PMID: 36292024 Free PMC article.
-
Inhibitory Effect of Styrylpyrone Extract of Phellinus linteus on Hepatic Steatosis in HepG2 Cells.Int J Mol Sci. 2023 Feb 12;24(4):3672. doi: 10.3390/ijms24043672. Int J Mol Sci. 2023. PMID: 36835095 Free PMC article.
-
Chemically synthesized osteocalcin alleviates NAFLD via the AMPK-FOXO1/BCL6-CD36 pathway.J Transl Med. 2024 Aug 22;22(1):782. doi: 10.1186/s12967-024-05592-y. J Transl Med. 2024. PMID: 39175012 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources